Mucodel Pharma Announces Patent Allowance for Mucodel’s Co-Gel Buccal Naloxone (Exonal™)
March 15, 2017 07:45 ET
|
Mucodel Pharma LLC
Greensboro, NC, March 15, 2017 (GLOBE NEWSWIRE) -- Mucodel Pharma LLC (“Mucodel”) announced today that it has received a notice of allowance from the United States Patent and Trademark Office for...
Mucodel Pharma Announces Successful Completion of Buccal Naloxone Pilot Clinical Study
September 21, 2016 07:45 ET
|
Mucodel Pharma LLC
GREENSBORO, N.C., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Mucodel Pharma LLC (“Mucodel”) today announced the successful completion of a pilot clinical study involving buccal naloxone (Exonal™), a...
Lightlake Therapeutics Inc.Announces Adapt Pharma Limited to Offer All U.S. High Schools a Free Narcan® (Naloxone Hydrochloride) Nasal Spray and Fund School-Based Opioid Overdose Education
January 27, 2016 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Facilitates NARCAN® (Naloxone Hydrochloride) Nasal Spray Access to 62,000 State and Local Public Entities
January 19, 2016 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Receives Milestone Payment for U.S. Food and Drug Administration Approval of NARCAN(R) (Naloxone Hydrochloride) Nasal Spray
December 15, 2015 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
BioCorRx, Inc. and MyLife Recovery CentersTM Announce Availability of the Start Fresh Program(r) for Treating Addiction in Washington, D.C.
March 09, 2015 07:00 ET
|
BioCorRx
Los Angeles, March 9, 2015 (GLOBE NEWSWIRE) -- BioCorRx,
Inc. (BICX), developer of the Start Fresh Program,
announces the opening of a new center offering the program in
Washington D.C. by its...
BioCorRx, Inc. Enters Agreement with Former Bosley, Inc. CEO and Medical Marketing Experts to Assist in Acquisition and Operation of Management Company
December 09, 2014 08:00 ET
|
BioCorRx
Los Angeles, Dec. 9, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc.
(BICX), developer of the Start Fresh Program®, announced today that
the company has entered into an agreement with EROI, LLC., which...
BioCorRx, Inc. Announces Availability of its Start Fresh Program for Treating Addiction in Oklahoma City, Oklahoma
December 04, 2014 13:51 ET
|
BioCorRx
Los Angeles, Dec. 4, 2014 (GLOBE NEWSWIRE) -- BioCorRx,
Inc. (BICX), developer of the Start Fresh Program®,
announces expansion into Oklahoma with the opening of a Start Fresh
Recovery...